ESC2014: Biotronik boasts of 'brilliant' biodegradable polymer stent data
This article was originally published in Clinica
Highlighted as one to watch before the meeting, Biotronik’s drug-eluting stent Orsiro was one of the success stories of ESC 2014. The sirolimus-eluting stent, which uses a biodegradable polymer, was shown to be noninferior to the market leader, Abbott’s everolimus-eluting Xience Prime, in the BIOSCIENCE study. Xience Prime was approved by the US FDA in 2011.